Form 8-K - Current report:
SEC Accession No. 0000950170-25-089118
Filing Date
2025-06-24
Accepted
2025-06-23 17:57:51
Documents
13
Period of Report
2025-06-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hura-20250623.htm   iXBRL 8-K 116017
2 EX-99.1 hura-ex99_1.htm EX-99.1 30578
3 GRAPHIC img112559081_0.jpg GRAPHIC 6926
4 GRAPHIC img112559081_1.jpg GRAPHIC 8492
  Complete submission text file 0000950170-25-089118.txt   294842

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hura-20250623.xsd EX-101.SCH 30873
16 EXTRACTED XBRL INSTANCE DOCUMENT hura-20250623_htm.xml XML 4717
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 251066125
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)